Page 6 - Mike Beyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aulos Bioscience Advances AU-007 to Phase 2 Portion of Phase 1/2 Study Evaluating Computationally Designed IL-2 Antibody for Treatment of Solid Tumors

LARKSPUR, Calif. (BUSINESS WIRE) Dec 18, 2023

United statesMike beyerAron knickerbockerSam brown incSociety for immunotherapy of cancerAulos bioscienceThese phaseAnnual meetingBiolojic designApple tree partnersSam brownBusiness wire

Allarity Therapeutics Announces Thomas Jensen as Interim CEO and Appointment of Jeremy R

Boston (December 12, 2023) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized

United statesThomash jensenMike beyerEli lillyJeremyr graffJamesg cullemThomas pedersenJerry mclaughlinJohns hopkins university school of medicineSmerud medical research internationalCarrotize pr communicationsExchange commissionCompany contactSam brown incAllarity therapeutics incScientific advisory board of avicenna biosciences inc

Coherus Announces Updated NCCN Clinical Practice Guidelines Positioning LOQTORZI™ (toripalimab-tpzi) as Preferred Category 1 Regimen for First-Line Treatment of Cancer of the Nasopharynx

Coherus Announces Updated NCCN Clinical Practice Guidelines Positioning LOQTORZI™ (toripalimab-tpzi) as Preferred Category 1 Regimen for First-Line Treatment of Cancer of the Nasopharynx
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJami taylorRosh diasJodi sieversMike beyerTarek mekhailCoherus biosciencesDrug administrationRed house communicationsVp corporate communicationsCoherus biosciences incAdventhealth cancer institute in orlandoNational comprehensive cancer networkAdministration in prescribing informationExchange commissionPreferred category

Allarity S Early Phase 2 Stenoparib Data Indicates Clinical Benefit In Women With Advanced Ovarian Cancer Selected With DRP® Companion Diagnostic

Allarity S Early Phase 2 Stenoparib Data Indicates Clinical Benefit In Women With Advanced Ovarian Cancer Selected With DRP® Companion Diagnostic
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesThomas pedersenStenoparib cdxMike beyerMarie foeghCompany contactEisai coSmerud medical research internationalExchange commissionAllarity therapeutics incCarrotize pr communicationsSam brown incCompany nasdaqChief medical officerDrug response predictorCompanion diagnostic

Philogen S p A ; Blue Earth Diagnostics: Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Philogen S p A ; Blue Earth Diagnostics: Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomStefan klotterDavid gaudenDario neriMike beyerEmanuele pucaBracco groupNational cancer institute of milanItalian stock exchangeSam brown incPhilogen groupFibroblast activation proteinBlue earth diagnosticsEarth diagnosticsBlue earthNational cancer institute